effective treatment
maintenance treatment
Glycomar’s eczema treatment
natural products
effect-free topical emollient treatment
atopic dermatitis
novel topical formulation
topical steroid creams
cosmetic products
non-pharma products
brown seaweed
procured seaweed
consumer healthcare
development pipeline
consumer preferences
steroid treatments
natural attributes
potential impact
itchy skin lesions
moderate AD sufferers
severe negative impact
Successful commercialisation of Fucoderm
chronic inflammatory skin disease
pursuit of novel immunomodulatory saccharides
non-dilutive grant funding
commercial application of Glycomar’s extensive glycobiology expertise
marine biotechnology
team
track record
years’ collective experience
nutraceutical
drug discovery
convenience
consumers
cash generative
long periods
steroids
quality of life
launch
active pharmaceutical ingredient
rashes
Fucoidan
value
partnerships
turn
prescription
shortcomings
high toxicity
profitability
child
target
b market
effects
adults
cases
company